|
Volumn 30, Issue 1, 2001, Pages 13-17
|
Treating depression in old age: The reasons to be positive
|
Author keywords
Depression; Old age; Treatment
|
Indexed keywords
ANTIDEPRESSANT AGENT;
DOSULEPIN;
FLUOXETINE;
LITHIUM;
NORTRIPTYLINE;
PERPHENAZINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
AGED;
BEHAVIOR THERAPY;
CLINICAL TRIAL;
COGNITIVE THERAPY;
COMMUNITY CARE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
DRUG TOLERABILITY;
ELDERLY CARE;
ELECTROCONVULSIVE THERAPY;
HEALTH CARE COST;
HEALTH SERVICE;
HUMAN;
LIFE EVENT;
LONELINESS;
MENTAL DISEASE;
MENTAL HEALTH;
MORBIDITY;
MORTALITY;
PATIENT COMPLIANCE;
PHYSICAL DISABILITY;
PHYSICAL DISEASE;
PRIORITY JOURNAL;
PROPHYLAXIS;
PSYCHOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
REVIEW;
RISK ASSESSMENT;
SIDE EFFECT;
SOCIAL ISOLATION;
SOCIAL WORK;
SUICIDE;
TREATMENT OUTCOME;
UNITED KINGDOM;
AGED;
ANTIDEPRESSIVE AGENTS;
COMBINED MODALITY THERAPY;
CROSS-SECTIONAL STUDIES;
DEPRESSIVE DISORDER;
ELECTROCONVULSIVE THERAPY;
ENGLAND;
FEMALE;
FRAIL ELDERLY;
HUMANS;
MALE;
PSYCHOTHERAPY;
SUICIDE;
|
EID: 0035074375
PISSN: 00020729
EISSN: None
Source Type: Journal
DOI: 10.1093/ageing/30.1.13 Document Type: Review |
Times cited : (75)
|
References (53)
|